These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 19253888)

  • 1. [Trends in blood transfusion indications].
    François A; Andreu G; Bierling P
    Rev Prat; 2009 Jan; 59(1):79-85. PubMed ID: 19253888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protecting the blood supply from emerging pathogens: the role of pathogen inactivation.
    Blajchman MA
    Transfus Clin Biol; 2009 May; 16(2):70-4. PubMed ID: 19427252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Giving blood: an individual right or the expression of a social responsibility? The donors' position in the debates on blood transfusion].
    Bastard B
    Transfus Clin Biol; 2006 Sep; 13(3):215-25. PubMed ID: 16959516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Platelet transfusion: products, indications, dose, threshold and efficacy].
    Andreu G; Vasse J; Tardivel R; Semana G
    Transfus Clin Biol; 2009 May; 16(2):118-33. PubMed ID: 19443257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfusion-transmitted infections.
    Bihl F; Castelli D; Marincola F; Dodd RY; Brander C
    J Transl Med; 2007 Jun; 5():25. PubMed ID: 17553144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in transfusion-transmitted viral infections from 2001 to 2006 in Ibadan, Nigeria.
    Fasola FA; Kotila TR; Akinyemi JO
    Intervirology; 2008; 51(6):427-31. PubMed ID: 19321928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diseases transmissible by transfusion: changing risks and new surveillance recommendations. Connecticut State Medical Society Committee on Organ and Tissue Transfers.
    Badon SJ; Cable RG
    Conn Med; 1994 Sep; 58(9):541-3. PubMed ID: 7956200
    [No Abstract]   [Full Text] [Related]  

  • 8. Changing trends in transfusion practice in liver transplantation.
    Ozier Y; Tsou MY
    Curr Opin Organ Transplant; 2008 Jun; 13(3):304-9. PubMed ID: 18685322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Issues in transfusion safety.
    Rushton AR; Jennings PR
    JAAPA; 2004 May; 17(5):39-42, 44, 46. PubMed ID: 15305503
    [No Abstract]   [Full Text] [Related]  

  • 10. Reducing replacement donors in Sub-Saharan Africa: challenges and affordability.
    Bates I; Manyasi G; Medina Lara A
    Transfus Med; 2007 Dec; 17(6):434-42. PubMed ID: 18067647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraoperative pediatric blood transfusion therapy: a review of common issues. Part I: hematologic and physiologic differences from adults; metabolic and infectious risks.
    Barcelona SL; Thompson AA; Coté CJ
    Paediatr Anaesth; 2005 Sep; 15(9):716-26. PubMed ID: 16101701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfusion medicine and safety.
    Dodd R; Kurt Roth W; Ashford P; Dax EM; Vyas G
    Biologicals; 2009 Apr; 37(2):62-70. PubMed ID: 19230706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evaluation of blood donor deferral causes.
    Gülen H; Tüzün F; Ayhan Y; Erbay A; Oztürk E; Inan S; Vergin C
    Pediatr Hematol Oncol; 2006 Mar; 23(2):91-4. PubMed ID: 16651236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biobanks and blood transfusion in France: a tool for public health].
    Lefrère JJ; Coudurier N
    Transfus Clin Biol; 2009 May; 16(2):148-51. PubMed ID: 19442557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Autologous transfusion program].
    Maamar M; Mojaat N; Ben Hamed L; Moula A; Hmida S; Boukef K
    Tunis Med; 2001 Mar; 79(3):141-5. PubMed ID: 11471441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How much blood is needed?
    Seifried E; Klueter H; Weidmann C; Staudenmaier T; Schrezenmeier H; Henschler R; Greinacher A; Mueller MM
    Vox Sang; 2011 Jan; 100(1):10-21. PubMed ID: 21175652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukocyte reduction's role in the attenuation of infection risks among transfusion recipients.
    Cervia JS; Wenz B; Ortolano GA
    Clin Infect Dis; 2007 Oct; 45(8):1008-13. PubMed ID: 17879916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reflections on the dynamics of bacterial and viral contamination of blood components and the levels of efficacy for pathogen inactivation processes.
    Bah A; Cardoso M; Seghatchian J; Goodrich RP
    Transfus Apher Sci; 2018 Oct; 57(5):683-688. PubMed ID: 30220450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of the professional practices of physicians in transfusion technology and medicine].
    Hergon E; Py JY; Jullien S; Quaranta JF; Folléa G; Andreu G; Cabaud JJ; Staccini P; Rouger P
    Transfus Clin Biol; 2007 Aug; 14(3):371-7. PubMed ID: 17604672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Infections of the gastrointestinal system--risk of transmission with blood and blood components].
    Korsak J
    Pol Merkur Lekarski; 2007 May; 22(131):502-4. PubMed ID: 17679406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.